Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.

J Bayliss, M Norell, R Canepa-Anson, G Sutton, P Poole-Wilson

The clinical and neuroendocrine response to diuretic treatment was assessed at rest and on exercise in 12 patients with heart failure. Before treatment all patients were limited by breathlessness on exercise; one was oedematous. Plasma renin activity and aldosterone were normal but plasma noradrenaline was raised both at rest and on exercise. After one month's treatment with frusemide (40 mg) and amiloride (5 mg) weight was significantly reduced by a mean of 3.5 kg and exercise capacity had doubled. Plasma noradrenaline fell to normal at rest but remained abnormally raised on exercise. Plasma renin activity and aldosterone increased significantly both at rest and on exercise. Diuretics bring about a considerable clinical improvement in patients with chronic heart failure but they stimulate the renin-angiotensin system. Activation of the renin-angiotensin system in moderate heart failure occurs as a response to diuretic treatment rather than as a result of the disease process itself.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Goodlin, S. J. (2009). Palliative care in congestive heart failure.. J Am Coll Cardiol 54: 386-396 [Abstract] [Full Text]  
• Winter, M M, Bouma, B J, Groenink, M, Konings, T C, Tijssen, J G P, van Veldhuisen, D J, Mulder, B J M (2009). Latest insights in therapeutic options for systemic right ventricular failure: a comparison with left ventricular failure. Heart 95: 960-963 [Abstract] [Full Text]  
• Felker, G. M., O'Connor, C. M., Braunwald, E., for the Heart Failure Clinical Research Network In, (2009). Loop Diuretics in Acute Decompensated Heart Failure: Necessary? Evil? A Necessary Evil?. Circ Heart Fail 2: 56-62 [Full Text]  
• Rosendorff, C., Black, H. R., Cannon, C. P., Gersh, B. J., Gore, J., Izzo, J. L. Jr, Kaplan, N. M., O'Connor, C. M., O'Gara, P. T., Oparil, S. (2007). REPRINT Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Hypertension 50: e28-e55 [Full Text]  
• Rosendorff, C., Black, H. R., Cannon, C. P., Gersh, B. J., Gore, J., Izzo, J. L. Jr, Kaplan, N. M., O'Connor, C. M., O'Gara, P. T., Oparil, S. (2007). Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 115: 2761-2788 [Full Text]  
• deGoma, E. M., Vagelos, R. H., Fowler, M. B., Ashley, E. A. (2006). Emerging Therapies for the Management of Decompensated Heart Failure: From Bench to Bedside. J Am Coll Cardiol 48: 2397-2409 [Abstract] [Full Text]  
• Ahmed, A., Husain, A., Love, T. E., Gambassi, G., Dell'Italia, L. J., Francis, G. S., Gheorghiade, M., Allman, R. M., Meleth, S., Bourge, R. C. (2006). Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J 27: 1431-1439 [Abstract] [Full Text]  
• Bourge, R. C., Tallaj, J. A. (2005). Ultrafiltration: A New Approach Toward Mechanical Diuresis in Heart Failure. J Am Coll Cardiol 46: 2052-2053 [Full Text]  
• Clark, A. L., Cleland, J. G.F. (2005). Anemia and Chronic Heart Failure: Are We Asking the Right Questions?. Circulation 112: 1681-1683 [Full Text]  
• Authors/Task Force Members, , Swedberg, K., Writing Committee:, , Cleland, J., Dargie, H., Drexler, H., Follath, F., Komajda, M., Tavazzi, L., Smiseth, O. A., Other Contributors, , Gavazzi, A., Haverich, A., Hoes, A., Jaarsma, T., Korewicki, J., Levy, S., Linde, C., Lopez-Sendon, J.-L., Nieminen, M. S., Pierard, L., Remme, W. J. (2005). Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26: 1115-1140 [Full Text]  
• Gupta, S., Neyses, L. (2005). Diuretic usage in heart failure: a continuing conundrum in 2005. Eur Heart J 26: 644-649 [Abstract] [Full Text]  
• Opie, L. H. (2004). Cellular Basis for Therapeutic Choices in Heart Failure. Circulation 110: 2559-2561 [Full Text]  
• McCurley, J. M., Hanlon, S. U., Wei, S.-k., Wedam, E. F., Michalski, M., Haigney, M. C. (2004). Furosemide and the progression of left ventricular dysfunction in experimental heart failure. J Am Coll Cardiol 44: 1301-1307 [Abstract] [Full Text]  
• Weber, K. T. (2004). Furosemide in the long-term management of heart failure: The good, the bad, and the uncertain. J Am Coll Cardiol 44: 1308-1310 [Full Text]  
• Kjaer, A., Appel, J., Hildebrandt, P., Petersen, C. L. (2004). Basal and exercise-induced neuroendocrine activation in patients with heart failure and in normal subjects. Eur J Heart Fail 6: 29-39 [Abstract] [Full Text]  
• El-Armouche, A., Zolk, O., Rau, T., Eschenhagen, T. (2003). Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure. Cardiovasc Res 60: 478-487 [Abstract] [Full Text]  
• Ohuchi, H., Takasugi, H., Ohashi, H., Okada, Y., Yamada, O., Ono, Y., Yagihara, T., Echigo, S. (2003). Stratification of Pediatric Heart Failure on the Basis of Neurohormonal and Cardiac Autonomic Nervous Activities in Patients With Congenital Heart Disease. Circulation 108: 2368-2376 [Abstract] [Full Text]  
• McKenzie, D B, Cowley, A J (2003). Drug therapy in chronic heart failure. Postgrad. Med. J. 79: 634-642 [Abstract] [Full Text]  
• van Kraaij, D. J.W., Jansen, R. W.M.M., Sweep, F. C.G.J., Hoefnagels, W. H.L. (2003). Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function. Eur J Heart Fail 5: 47-53 [Abstract] [Full Text]  
• Marenzi, G., Lauri, G., Assanelli, E., Grazi, M., Campodonico, J., Famoso, G., Agostoni, P. (2002). Serum to urinary sodium concentration ratio is an estimate of plasma renin activity in congestive heart failure. Eur J Heart Fail 4: 597-603 [Abstract] [Full Text]  
• Poole-Wilson, P. A., Cleland, J. G.F., Di Lenarda, A., Hanrath, P., Komajda, M., Metra, M., Remme, W. J., Swedberg, K., Torp-Pedersen, C. (2002). Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET. Eur J Heart Fail 4: 321-329 [Abstract] [Full Text]  
• Johnson, W., Omland, T., Hall, C., Lucas, C., Myking, O. L., Collins, C., Pfeffer, M., Rouleau, J.-L., Stevenson, L. W. (2002). Neurohormonal activation rapidly decreases after intravenous therapy withdiuretics and vasodilators for class IV heart failure. J Am Coll Cardiol 39: 1623-1629 [Abstract] [Full Text]  
• Ferrara, R, Mastrorilli, F, Pasanisi, G, Censi, S, D'aiello, N, Fucili, A, Valgimigli, M, Ferrari, R (2002). Neurohormonal modulation in chronic heart failure. Eur Heart J Suppl 4: D3-D11 [Abstract]  
• Zannad, F (2002). Evidence-based drug therapy for chronic heart failure. Eur Heart J Suppl 4: D66-D72 [Abstract]  
• Braunschweig, F., Linde, C., Eriksson, M.J., Hofman-Bang, C., Ryden, L. (2002). Continous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure. Eur Heart J 23: 59-69 [Abstract] [Full Text]  
• Cowburn, P.J., Cleland, J.G.F. (2001). Endothelin antagonists for chronic heart failure: do they have a role?. Eur Heart J 22: 1772-1784  
• Task Force for the Diagnosis and Treatment of Chro, , Remme, W. J., Swedberg, K. (2001). Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22: 1527-1560  
• Roguin, A., Behar, D. M., Ami, H. B., Reisner, S. A., Edelstein, S., Linn, S., Edoute, Y. (2000). Long-term prognosis of acute pulmonary oedema -- an ominous outcome. Eur J Heart Fail 2: 137-144 [Abstract] [Full Text]  
• Dutka, D. P., Puri, S., Strong, R., Cleland, J. G.F. (1999). Disruption of the relationship between renin and atrial natriuretic peptide early in the course of ventricular dysfunction. Eur J Heart Fail 1: 371-377 [Abstract] [Full Text]  
• Abraham, W. T. (1998). Pharmacologic Management of Chronic Heart Failure: A Review. SEMIN CARDIOTHORAC VASC ANESTH 2: 168-190 [Abstract]  
• James, K. B., McCarthy, P. M., Jaalouk, S., Bravo, E. L., Betkowski, A., Thomas, J. D., Nakatani, S., Fouad-Tarazi, F. M. (1996). Plasma Volume and Its Regulatory Factors in Congestive Heart Failure After Implantation of Long-term Left Ventricular Assist Devices. Circulation 93: 1515-1519 [Abstract] [Full Text]  
• James, K. B., McCarthy, P. M., Thomas, J. D., Vargo, R., Hobbs, R. E., Sapp, S., Bravo, E. (1995). Effect of the Implantable Left Ventricular Assist Device on Neuroendocrine Activation in Heart Failure. Circulation 92: 191-195 [Abstract] [Full Text]  
• COMMITTEE MEMBERS, , WILLIAMS, J. F. Jr, BRISTOW, M. R., FOWLER, M. B., FRANCIS, G. S., GARSON, A. Jr, GERSH, B. J., HAMMER, D. F., HLATKY, M. A., LEIER, C. V., PACKER, M., PITT, B., ULLYOT, D. J., WEXLER, L. F., WINTERS, W. L. Jr, TASK FORCE MEMBERS, , RITCHIE, J. L., CHEITLIN, M. D., EAGLE, K. A., GARDNER, T. J., GARSON, A. Jr, GIBBONS, R. J., LEWIS, R. P., O'ROURKE, R. A., RYAN, T. J. (1995). Guidelines for the Evaluation and Management of Heart Failure : Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). Circulation 92: 2764-2784 [Full Text]  
• Cody, R. J., Kubo, S. H., Pickworth, K. K. (1994). Diuretic Treatment for the Sodium Retention of Congestive Heart Failure. Arch Intern Med 154: 1905-1914 [Abstract]  
• Feldman, A. M. (1992). Can We Alter Survival in Patients With Congestive Heart Failure?. JAMA 267: 1956-1961 [Abstract]  
• The Captopril-Digoxin Multicenter Research Group, , Cohn, J., Hawkins, M., Levine, H., Naughton, J., Rapaport, E., Goldstein, S., Pitt, B., Goldstein, S., Cody, R., Deedwania, P., Dennick, L., Franciosa, J., McGovern, M., Meyer, J., Pitt, B., Franciosa, J., Goldstein, S., Cody, R., Deedwania, P., Gradman, A., Massie, B., Packer, M., Doherty, J., Gammill, J., Cooper, W., Engel, S., Fand, R., Hallows, B., Kerwin, L., Soltesz, D. A., Parker, J. O., Lahey, K., Deedwania, P. C., Carbajal, E., Watson, P., DiBianco, R., Ronan, J. A., Donohue, D. J., Lindgren, K. M., Larca, L. J., Freitag, J., Lindemuth, D., Lakier, J. B., Rosman, H. S., Wlodkowski, M. B., Cody, R. J., Kubo, S. H., Clark, M., Pondolfino, K., Franciosa, J. A., Wilen, M., Jordan, D., Das, S. K., Nicklas, J. M., Foley, M. K., Higginbotham, M. B., Cobb, F. R., Wilson, J., Berkson, D. M., Obradovic, D., Hershinow, P., Nicholls, N. G., Ikram, H., Crozier, I., Pepine, C. J., Culp, J., Limacher, M., Mulvehill-Verbust, K., Farnham, D. J., Adams, D., Streicher, N., Shanley, C., Greenberg, M. A., Strain, J., Hewitt, M., Levine, B., Sharpe, D. N., Briant, R., Coxon, R., Massie, B. M., Cornyn, J. W., Topic, N., Willens, H., Antonishen, D., Reinstein, D., Colfer, H., Graham, K. E., Perlow, G. M., Zarren, H. S., Bent, B., Zicherman, M., Gradman, A., Zaret, B., Lawrason, D., Tellier, P., O'Keefe, K., Mohiuddin, S., Stengel, L., Madison, J. D., Carruthers, N., Packer, M., Elijovich, F., O'Sullivan, M., Elkayam, U., Rahimtoola, S. H., Weber, L., Gottlieb, S., Brown, C., Jessup, M. D., Ulrich, S., Kronenthal, J., Capaccio, D., Grant, C., Gillie, E., Wood, P., Fouad-Tarazi, F. M., Petey, K. (1988). Comparative Effects of Therapy With Captopril and Digoxin in Patients With Mild to Moderate Heart Failure. JAMA 259: 539-544 [Abstract]